Journey Medical (DERM) Gains from Investment Securities (2020 - 2025)
Historic Gains from Investment Securities for Journey Medical (DERM) over the last 6 years, with Q1 2025 value amounting to $2.8 million.
- Journey Medical's Gains from Investment Securities rose 571.9% to $2.8 million in Q1 2025 from the same period last year, while for Sep 2025 it was $118000.0, marking a year-over-year decrease of 3257.14%. This contributed to the annual value of $125000.0 for FY2024, which is 3093.92% down from last year.
- Latest data reveals that Journey Medical reported Gains from Investment Securities of $2.8 million as of Q1 2025, which was up 571.9% from $21000.0 recorded in Q4 2024.
- Journey Medical's Gains from Investment Securities' 5-year high stood at $3.3 million during Q2 2022, with a 5-year trough of -$352425.0 in Q3 2022.
- Over the past 5 years, Journey Medical's median Gains from Investment Securities value was $87000.0 (recorded in 2023), while the average stood at $788601.2.
- As far as peak fluctuations go, Journey Medical's Gains from Investment Securities tumbled by 9896.3% in 2023, and later surged by 3808172.86% in 2024.
- Journey Medical's Gains from Investment Securities (Quarter) stood at $1000.0 in 2021, then skyrocketed by 14800.0% to $149000.0 in 2022, then tumbled by 35.57% to $96000.0 in 2023, then plummeted by 78.12% to $21000.0 in 2024, then surged by 13355.11% to $2.8 million in 2025.
- Its Gains from Investment Securities was $2.8 million in Q1 2025, compared to $21000.0 in Q4 2024 and $1000.0 in Q3 2024.